Du BN, et al. Sci China Chem August (2014) Vol.57 No.8
1177
C−N bond formation via multiple sp3 C−H bond activation
of easily available and inexpensive methylarenes, providing
an efficient approach to arylamides.
168.4, 136.4, 130.3, 130.1, 129.5, 127.7, 127.2, 38.0, 34.6.
1
3-Chloro-N,N-dimethylbenzamide (3ea) [15]: H NMR
(400 MHz, CDCl3) δ 7.41–7.29 (m, 4H), 3.11 (s, 3H), 2.98
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.0, 138.0,
134.42, 129.8, 129.6, 127.2, 125.1, 39.5, 35.4.
1
2 Experimental
4-Chloro-N,N-dimethylbenzamide (3fa) [15]: H NMR
(400 MHz, CDCl3) δ 7.40–7.35 (m, 4H), 3.10 (s, 3H), 2.97
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.5, 135.6, 134.7,
130.9, 128.6, 39.5, 35.4.
2.1 General information
1
All reactions were run in a sealed tube with a Teflon lined
cap under air atmosphere. All chemical reagents and sol-
vents were purchased from Aldrich, Alfa Aesar and Si-
nopharm chemical reagent Co. Ltd., and were used without
4-Cyano-N,N-dimethylbenzamide (3ga) [15]: H NMR
(400 MHz, CDCl3) δ 7.90 (d, J = 6.8 Hz, 2H), 7.49 (d, J =
6.8 Hz, 2H), 3.12 (s, 3H), 2.96 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 190.3, 166.5, 141.3, 131.5, 131.0, 129.4, 37.0,
34.1.
1
further purification. H NMR (400 MHz) and 13C NMR
1
(100 MHz) spectra were recorded on a Bruker Avance 400
Methyl 4-(dimethylcarbamoyl)benzoate (3ha) [13]: H
1
spectrometers in CDCl3 (using (CH3)4Si (for H, δ = 0.00;
NMR (400 MHz, CDCl3) δ 8.10 (d, J = 8.0 Hz, 2H), 7.50 (d,
J = 8.0 Hz, 2H), 3.96 (s, 3H) 3.15 (s, 3H), 2.98 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 170.6, 166.4, 140.7, 131.0,
129.7, 127.0, 52.3, 39.4, 35.3.
for 13C, δ = 77.00) as internal standard). The following ab-
breviations were used to explain the multiplicities: s = sin-
glet, d = doublet, t = triplet, q = quartet, m = multiplet.
1
3-Methoxy-N,N-dimethylbenzamide (3ia) [14]: H NMR
2.2 General experimental procedures and characteri-
zations
(400 MHz, CDCl3) δ 7.33–7.29(m, 1H), 6.98–6.93 (m, 3H),
3.83 (s, 3H), 3.11 (s, 3H), 2.98 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 171.4, 159.5, 137.7, 129.4, 119.1, 115.4, 112.4,
55.3, 39.5, 35.3.
Toluene derivatives 1 (1.0 mmol), I2 (0.2 mmol), TBHP (3.0
mmol), NaOH (0.4 mmol) and H2O (1 mL) were added in a
25 mL sealed tube with a Teflon lined cap. Then
N,N-dialkylformamides 2 (6.0 mmol) and TBHP (5.0 mmol)
were added in batches. The mixture was stirred in an oil
bath at 80 oC. After 20 h, the reaction mixture was cooled to
room temperature, and diluted with water, then extracted
with ethyl acetate (15 mL × 3). The combined organic layer
was washed with water and dried with anhydrous Na2SO4,
the solvent was then removed under vacuum. The residue
was purified by flash column chromatography on silica gel
using hexane/ethyl acetate as eluent to give the correspond-
ing product.
3,4-Dichloro-N,N-dimethylbenzamide (3ja) [19]: 1H
NMR (400 MHz, CDCl3) δ 7.53 (s, 1H), 7.49 (d, J = 8.4 Hz,
1H), 7.26 (d, J = 8.4 Hz, 1H), 3.10 (s, 3H), 2.99 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 169.1, 136.1, 133.9, 132.8,
130.5, 129.3, 126.4, 39.5, 35.4.
N,N,3-trimethylbenzamide (3ka) [15]: 1H NMR (400
MHz, CDCl3) δ 7.26–7.17 (m, 4H), 3.09 (s, 3H), 2.96 (s,
3H), 2.36 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.8,
138.2, 136.3, 130.2, 128.1, 127.6, 123.9, 39.6, 35.3, 21.3.
N,N,4-trimethylbenzamide (3la) [15]: 1H NMR (400
MHz, CDCl3) δ 7.32 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 8.0 Hz,
2H), 3.05 (s, 6H), 2.38 (s, 3H); 13C NMR (100 MHz, CDCl3)
δ 171.8, 139.6, 133.3, 128.9, 127.2, 39.7, 35.4, 21.4.
N,N,3,5-tetramethylbenzamide (3ma) [20]: 1H NMR
(400 MHz, CDCl3) δ 7.03 (s, 1H), 7.01 (s, 2H), 3.10 (s, 3H),
2.97 (s, 3H), 2.33 (s, 6H); 13C NMR (100 MHz, CDCl3) δ
172.0, 137.9, 136.3, 131.0, 124.6, 39.6, 35.2, 21.2.
1
All products are known compounds. The H NMR and
13C NMR spectra can be seen in the Supporting Information
online. The 1H NMR and 13C NMR data are shown below:
N,N-dimethylbenzamide (3aa) [15]: 1H NMR (400 MHz,
CDCl3) δ 7.41–7.28 (m, 5H), 3.08 (s, 3H), 2.91 (s, 3H); 13
C
1
NMR (100 MHz, CDCl3) δ 171.6, 136.4, 129.5, 128.3,
N,N-diethylbenzamide (3ab) [15]: H NMR (400 MHz,
127.0, 39.6, 35.3.
CDCl3) δ 7.40–7.34 (m, 5H), 3.55 (s, 2H), 3.26 (s, 2H),
1.27–1.24 (m, 3H), 1.21–1.11 (m,3H); 13C NMR (100 MHz,
CDCl3) δ 171.3, 137.3, 129.1, 128.4, 126.3, 43.3, 39.2, 14.2,
12.9.
1
4-Fluoro-N,N-dimethylbenzamide (3ba) [15]: H NMR
(400 MHz, CDCl3) δ 7.45–7.41 (m, 2H), 7.11–7.06 (m, 2H),
3.10 (s, 3H), 2.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
170.7, 164.5, 162.0, 132.3, 132.2, 129.4, 129.3, 115.5,
115.3, 58.3, 39.6, 35.9.
1
Phenyl(piperidin-1-yl)methanone (3ac) [15]: H NMR
(400 MHz, CDCl3) δ 7.40 (m, 5H), 3.72 (s, 2H), 3.34 (s,
2H), 1.68 (s, 4H), 1.53 (s, 2H); 13C NMR (100 MHz, CDCl3)
δ 170.3, 136.5, 129.3, 128.4, 126.8, 48.7, 43.1, 26.4, 25.6,
24.6.
1
4-Bromo-N,N-dimethylbenzamide (3ca) [15]: H NMR
(400 MHz, CDCl3) δ 7.53 (d, J = 8.8 Hz, 2H), 7.29 (d, J =
8.8 Hz, 2H), 3.08 (s, 3H), 2.96 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 170.5, 135.1, 131. 6, 128.8, 123.8, 39.5, 35.4.
1
4-Benzoylmorpholine (3ad) [15]: H NMR (400 MHz,
1
2-Chloro-N,N-dimethylbenzamide (3da) [14]: H NMR
CDCl3) δ 7.45–7.40 (m, 5H), 3.76–3.66 (m, 6H), 3.53–3.47
(m, 2H); 13C NMR (100 MHz, CDCl3) δ 170.5, 135.3, 129.9,
128.6, 127.1, 66.9, 48.2, 42.6.
(400 MHz, CDCl3) δ 7.39–7.36 (m, 1H), 7.31–7.27 (m, 3H),
3.12 (s, 3H), 2.84 (s, 3H); 13C NMR (100 MHz, CDCl3) δ